Bisphosphonate Quiz: Can You Teach Safe Dosing?

Submit

2. Adequate calcium and vitamin D intake is essential during bisphosphonate therapy. True or False?

True

False

3. Which of the following is a risk factor for bisphosphonate-related osteonecrosis of the jaw?

Age

Prolonged IV bisphosphonate use

Good oral hygiene

Recent viral infection

Submit

5. A patient on bisphosphonates reports severe, persistent bone pain lasting months. What nursing action is most appropriate?

Increase the bisphosphonate dose

Discontinue the medication and report to provider

Reassure the patient this is expected

Add an NSAID without provider consultation

Submit

7. Which vitamin supplement should be encouraged in patients taking bisphosphonates?

Vitamin A

Vitamin C

Vitamin D

Vitamin E

8. Bisphosphonates are contraindicated in pregnancy. True or False?

True

False

9. A patient reports nausea, vomiting, and muscle cramps after IV zoledronic acid. These symptoms may indicate which electrolyte abnormality?

Hypernatremia

Hypocalcemia

Hyperkalemia

Hypomagnesemia

Submit

11. Which bisphosphonate is the preferred agent for hypercalcemia of malignancy?

Alendronate

Risedronate

Zoledronic acid

Ibandronate

12. Which bisphosphonate is administered intravenously every 4 weeks for osteoporosis treatment?

Alendronate

Zoledronic acid

Risedronate

Ibandronate

13. A patient on long-term bisphosphonate therapy presents with a subtrochanteric fracture without significant trauma. This is consistent with which complication?

Atypical femoral fracture

Pathologic fracture

Stress fracture

Avascular necrosis

Submit

15. Which patient would be contraindicated for bisphosphonate therapy?

Creatinine clearance

History of osteoporosis

Age >65 years

Vitamin D deficiency

16. A patient must remain upright for at least 30 minutes after taking oral alendronate. True or False?

True

False

Submit

18. Which lab value must be monitored in patients receiving IV bisphosphonates?

Serum calcium

Liver enzymes

Platelet count

Glucose level

19. A patient on bisphosphonate therapy develops muscle and bone pain unrelated to osteoporosis. What is this adverse effect called?

Atypical fracture

Bisphosphonate-related osteonecrosis

Atypical musculoskeletal pain

Spontaneous fracture syndrome

Submit

21. A patient taking alendronate reports severe jaw pain and loose teeth. This clinical presentation suggests which adverse effect?

Osteonecrosis of the jaw

Hypocalcemia

Esophageal stricture

Atrial fibrillation

Bisphosphonate Quiz: Can You Teach Safe Dosing?

1. Bisphosphonates should not be taken within ____ hours of other oral medications to avoid drug interactions.

2.

What first name or nickname would you like us to use?

2. Adequate calcium and vitamin D intake is essential during bisphosphonate therapy. True or False?

3. Which of the following is a risk factor for bisphosphonate-related osteonecrosis of the jaw?

4. Bisphosphonates should be held for ____ days before and after dental surgery.

5. A patient on bisphosphonates reports severe, persistent bone pain lasting months. What nursing action is most appropriate?

6. Ibandronate can be administered as ____ mg IV every 3 months or orally.

7. Which vitamin supplement should be encouraged in patients taking bisphosphonates?

8. Bisphosphonates are contraindicated in pregnancy. True or False?

9. A patient reports nausea, vomiting, and muscle cramps after IV zoledronic acid. These symptoms may indicate which electrolyte abnormality?

10. Before starting bisphosphonate therapy, baseline assessment should include bone mineral density and ____.

11. Which bisphosphonate is the preferred agent for hypercalcemia of malignancy?

12. Which bisphosphonate is administered intravenously every 4 weeks for osteoporosis treatment?

13. A patient on long-term bisphosphonate therapy presents with a subtrochanteric fracture without significant trauma. This is consistent with which complication?

14. Risedronate dosing for osteoporosis prevention is typically mg weekly or mg daily.

15. Which patient would be contraindicated for bisphosphonate therapy?

16. A patient must remain upright for at least 30 minutes after taking oral alendronate. True or False?

17. Bisphosphonates work by inhibiting ____.

18. Which lab value must be monitored in patients receiving IV bisphosphonates?

19. A patient on bisphosphonate therapy develops muscle and bone pain unrelated to osteoporosis. What is this adverse effect called?

20. To minimize esophageal irritation, alendronate must be taken with ____.

21. A patient taking alendronate reports severe jaw pain and loose teeth. This clinical presentation suggests which adverse effect?

Bisphosphonate Quiz: Can You Teach Safe Dosing?

1. Bisphosphonates should not be taken within ____ hours of other oral medications to avoid drug interactions.

2.

What first name or nickname would you like us to use?

2. Adequate calcium and vitamin D intake is essential during bisphosphonate therapy. True or False?

3. Which of the following is a risk factor for bisphosphonate-related osteonecrosis of the jaw?

4. Bisphosphonates should be held for ____ days before and after dental surgery.

5. A patient on bisphosphonates reports severe, persistent bone pain lasting months. What nursing action is most appropriate?

6. Ibandronate can be administered as ____ mg IV every 3 months or orally.

7. Which vitamin supplement should be encouraged in patients taking bisphosphonates?

8. Bisphosphonates are contraindicated in pregnancy. True or False?

9. A patient reports nausea, vomiting, and muscle cramps after IV zoledronic acid. These symptoms may indicate which electrolyte abnormality?

10. Before starting bisphosphonate therapy, baseline assessment should include bone mineral density and ____.

11. Which bisphosphonate is the preferred agent for hypercalcemia of malignancy?

12. Which bisphosphonate is administered intravenously every 4 weeks for osteoporosis treatment?

13. A patient on long-term bisphosphonate therapy presents with a subtrochanteric fracture without significant trauma. This is consistent with which complication?

14. Risedronate dosing for osteoporosis prevention is typically ____ mg weekly or ____ mg daily.

15. Which patient would be contraindicated for bisphosphonate therapy?

16. A patient must remain upright for at least 30 minutes after taking oral alendronate. True or False?

17. Bisphosphonates work by inhibiting ____.

18. Which lab value must be monitored in patients receiving IV bisphosphonates?

19. A patient on bisphosphonate therapy develops muscle and bone pain unrelated to osteoporosis. What is this adverse effect called?

20. To minimize esophageal irritation, alendronate must be taken with ____.

21. A patient taking alendronate reports severe jaw pain and loose teeth. This clinical presentation suggests which adverse effect?

14. Risedronate dosing for osteoporosis prevention is typically mg weekly or mg daily.